{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 24, "transaction_limit": 160, "filters": {"q": "", "ticker": "NBIX", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 24, "acquisition_count": 8, "disposal_count": 16, "acquisition_value": 3601179.26, "acquisition_value_label": "$3.6M", "disposal_value": 6891132.4207, "disposal_value_label": "$6.9M", "net_value": -3289953.1607, "net_value_label": "$-3.3M", "flow_tone": "negative", "largest_value_label": "$1.8M", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 24, "value": "10492311.6807", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$10.5M"}], "days": [{"transaction_date": "2026-06-26", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 50.0}, {"transaction_date": "2026-06-29", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 100.0}, {"transaction_date": "2026-07-07", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 50.0}, {"transaction_date": "2026-07-08", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 50.0}, {"transaction_date": "2026-07-09", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 100.0}, {"transaction_date": "2026-07-10", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 50.0}], "side_mix": {"acquisitions": 8, "disposals": 16, "acquisition_share": 33.3, "disposal_share": 66.7}}, "company_flows": [{"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-07-10", "acquisitions": 8, "disposals": 16, "acquired_value": 3601179.26, "acquired_value_label": "$3.6M", "disposed_value": 6891132.4207, "disposed_value_label": "$6.9M", "net_value": -3289953.1607, "net_value_label": "$-3.3M", "acquisition_share": 33.3, "disposal_share": 66.7, "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}], "company_overview": [{"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-07-10", "filings": 24, "acquisitions": 8, "disposals": 16, "acquired_value": 3601179.26, "acquired_value_label": "$3.6M", "disposed_value": 6891132.4207, "disposed_value_label": "$6.9M", "net_value": -3289953.1607, "net_value_label": "$-3.3M", "acquisition_share": 33.3, "disposal_share": 66.7, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}], "transactions": [{"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4367.0, "share_price": 181.02, "transaction_value": 790514.34, "fetched_at": "2026-07-30T21:46:17.972414+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4367.0, "share_price": 106.02, "transaction_value": 462989.34, "fetched_at": "2026-07-30T21:46:17.979599+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 4367.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:46:17.982170+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-09", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 179.6014, "transaction_value": 1796014.0, "fetched_at": "2026-07-30T21:46:17.985521+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-09", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8433.0, "share_price": 178.7187, "transaction_value": 1507134.7971, "fetched_at": "2026-07-30T21:46:17.983938+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-09", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8433.0, "share_price": 103.52, "transaction_value": 872984.16, "fetched_at": "2026-07-30T21:46:17.988370+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-09", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 81.49, "transaction_value": 814900.0, "fetched_at": "2026-07-30T21:46:17.990079+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-09", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 8433.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:46:17.986956+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-09", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:46:17.991444+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-08", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2737.0, "share_price": 178.543, "transaction_value": 488672.191, "fetched_at": "2026-07-28T22:02:41.785333+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-08", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2737.0, "share_price": 103.52, "transaction_value": 283334.24, "fetched_at": "2026-07-28T22:02:41.784021+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-08", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 2737.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-28T22:02:41.786619+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-07", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3401.0, "share_price": 178.5666, "transaction_value": 607305.0066, "fetched_at": "2026-07-28T22:02:41.790438+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-07", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3401.0, "share_price": 103.52, "transaction_value": 352071.52, "fetched_at": "2026-07-28T22:02:41.787862+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-07", "executive": "DELAET, INGRID", "executive_title": "Chief Regulatory Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 3401.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-28T22:02:41.789220+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-29", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8110.0, "share_price": 170.025, "transaction_value": 1378902.75, "fetched_at": "2026-07-20T10:48:06.806274+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-29", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8110.0, "share_price": 81.49, "transaction_value": 660883.9, "fetched_at": "2026-07-20T10:48:06.796602+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-29", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1690.0, "share_price": 170.8144, "transaction_value": 288676.336, "fetched_at": "2026-07-20T10:48:06.802077+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-29", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1690.0, "share_price": 81.49, "transaction_value": 137718.1, "fetched_at": "2026-07-20T10:48:06.804056+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-29", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 1690.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T10:48:06.798646+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-29", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 8110.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T10:48:06.800056+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-26", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 200.0, "share_price": 169.565, "transaction_value": 33913.0, "fetched_at": "2026-07-16T11:04:01.823405+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-26", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 200.0, "share_price": 81.49, "transaction_value": 16298.0, "fetched_at": "2026-07-16T11:04:01.825061+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}, {"symbol": "NBIX", "name": "Neurocrine Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-26", "executive": "LIPPOLDT, DARIN", "executive_title": "Chief Legal Officer", "security_type": "Non-Qualified Stock Option", "side_code": "D", "side": "Disposal", "shares": 200.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T11:04:01.826732+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nbix/", "research_links": {"chart": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/", "report": "/terminal/13329539-a11a-4f6e-acd2-e0ab10d746a9/report/", "factor": "/factors/ticker/13329539-a11a-4f6e-acd2-e0ab10d746a9/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}